| 1 | 2923-09-3 | 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 5-chloro-7-[[[3-(diethylamino)propyl]amino]methyl]-8-quinolinol (1:1) (9CI) | C23H16O6.C17H24ClN3O | | | |
| 2 | 2923-14-0 | silver(1+) chlorodifluoroacetate | C2AgClF2O2 | 237.3382064 | | |
| 3 | 2923-15-1 | mercury(1+) trifluoroacetate | C2F3HgO2 | 313.6054096 | | |
| 4 | 2923-16-2 | potassium trifluoroacetate | C2F3KO2 | 152.11 | 140-142 °C (lit.) | Soluble in water. |
| 5 | 2923-17-3 | Lithium Trifluoroacetate | C2F3LiO2 | 119.96 | 250℃ | |
| 6 | 2923-18-4 | Trifluoroacetic acid,sodium salt | C2F3NaO2 | 136.01 | 205-207 °C (dec.) (lit.) | 625 g/L (25 ºC) |
| 7 | 2923-20-8 | Ethanesulfonic acid, 1,1,2,2,2-pentafluoro-, lithium salt (1:1) | C2HF5O3S.Li | | | |
| 8 | 2923-22-0 | BETA-FLUOROPYRUVIC ACID SODIUM SALT | C3H2FNaO3 | 128.03 | 145°C | |
| 9 | 2923-26-4 | SODIUM PERFLUOROHEXANOATE | C6H2F11NaO2 | 338.05 | | |
| 10 | 2923-28-6 | silver trifluoromethanesulfonate | CAgF3O3S | 256.94 | 286 °C (lit.) | Soluble in water and also in most organic solvents. |
| 11 | 2923-41-3 | Chloro[4-(trifluoromethyl)phenyl]magnesium | C7H4ClF3Mg | 204.86 | | |
| 12 | 2923-56-0 | 4-(Trifluoromethyl)phenylhydrazine hydrochloride | C7H8ClF3N2 | 212.6 | 200 °C | |
| 13 | 2923-59-3 | Aceticacid, 2-(2-fluoro-4,6-dinitrophenoxy)- | C8H5FN2O7 | 260.13 | | |
| 14 | 2923-61-7 | Acetic acid,2-(5-fluoro-2,4-dinitrophenoxy)- | C8H5FN2O7 | 260.1329032 | | |
| 15 | 2923-66-2 | 3-Chloro-4-fluoroacetophenone | C8H6ClFO | 172.58 | 42 °C | |
| 16 | 2923-68-4 | 3,5,7,8-TETRACHLOROPERFLUOROOCTANOIC ACID | C8HCl4F11O2 | 479.89 | | |
| 17 | 2923-73-1 | 2'-Fluoro-2'-deoxythymidine | C10H13FN2O5 | 260.22 | | |
| 18 | 2923-83-3 | Phenol, 2,4-bis(1,1-dimethylethyl)-5-fluoro- | C14H21FO | 224.31 | | |
| 19 | 2923-84-4 | Benzenemethanamine,N,N-bis(2-fluoroethyl)-3,4,5-trimethoxy-, hydrochloride (1:1) | C14H22ClF2NO3 | 325.7791864 | | |
| 20 | 2923-90-2 | Uridine, 2'-deoxy-2'-fluoro-5'-O-(triphenylmethyl)- (9CI) | C28H25FN2O5 | 488.51 | | |
| 21 | 2923-93-5 | N-[4-(2,2,3,3,4,4,4-HEPTAFLUOROBUTYRAMIDO)-3-HYDROXYPHENYL]-2-(2,4-DI-T-PENTYLPHENOXY)HEXANAMIDE | C32H41F7N2O4 | 650.67 | | |
| 22 | 2923-94-6 | 6-fluoro-3H-1,3-benzoxazol-2-one | C7H4FNO2 | 153.111 | | |
| 23 | 2923-96-8 | 4-Fluoro-2-nitrobenzaldehyde | C7H4FNO3 | 169.11 | 32-33 °C | |
| 24 | 2923-98-0 | Benzaldehyde, 5-fluoro-2-hydroxy-3-nitro- | C7H4FNO4 | 185.11 | | |
| 25 | 2923-99-1 | 3-fluoro-2-hydroxy-5-nitrobenzaldehyde | C7H4FNO4 | 185.11 | | |
| 26 | 29230-19-1 | Butanamide, N-(5-bromo-2-thiazolyl)- | C7H9BrN2OS | 249.13 | | |
| 27 | 29230-20-4 | N-(5-bromothiazol-2-yl)benzamide | C10H7BrN2OS | 283.14 | | |
| 28 | 29230-99-7 | Carbamic acid, N,N-dimethyl-, 2-acetylphenyl ester | C11H13NO3 | 207.23 | | |
| 29 | 2923008-44-8 | WRN inhibitor 1 | | | | |
| 30 | 2923008-66-4 | (R)-6-cyclohexyl-N-(1,1-dioxido-2,3-dihydrothiophen-3-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide | C16H20N2O4S | 336.41 | | |
| 31 | 2923009-45-2 | WRN inhibitor 4 | C16H14N2O5S | 346.36 | | |
| 32 | 2923009-48-5 | WRN inhibitor 3 | C20H20N2O5S | 400.45 | | |
| 33 | 2923009-50-9 | GSK_WRN3 | C16H20N2O5S | 352.41 | | |
| 34 | 2923009-51-0 | 3-Pyridinecarboxamide, 6-cyclohexyl-N-[(3S)-2,3-dihydro-1,1-dioxido-3-thienyl]-1,2-dihydro-5-hydroxy-2-oxo- | C16H20N2O5S | 352.41 | | |
| 35 | 2923009-56-5 | WRN inhibitor 2 | C15H11F3N2O5S2 | 420.39 | | |
| 36 | 2923009-95-2 | WRN inhibitor 5 | C23H20N2O6S | 452.48 | | |
| 37 | 2923011-07-6 | Methyl 6-chloro-5-hydroxy-2-methoxynicotinate | C8H8ClNO4 | 217.61 | | |
| 38 | 2923012-24-0 | Atuveciclib | C18H18FN5O2S | 387.43 | | |
| 39 | 2923054-94-6 | HKYK-0030 | C14H11ClN4O5S | 382.78 | | |
| 40 | 2923068-30-6 | (2S)-2-[[(1S)-5-[[4-[2-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2R)-1-[[(2S)-1-amino-6-[[(4S)-4-[[4-[(2-amino-4-oxo-8H-pteridin-6-yl)methylamino]benzoyl]amino]-4-carboxybutanoyl]amino]-1-oxohexan-2-yl]amino]-3-[1-[6-[[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2,5-dioxopyrrolidin-3-yl]sulfanyl-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-2-oxoethyl]phenyl]methylcarbamoylamino]-1-carboxypentyl]carbamoylamino]pentanedioic acid | C132H192N30O38S | 2839.19 | | |
| 41 | 2923072-93-7 | 2-(tert-butyl)-12-phenyl-5,12-dihydroindolo[3,2-a]carbazole | | | | |
| 42 | 29231-68-3 | 5-hydrazino-3-(methylthio)isothiazole-4-carbonitrile | C5H6N4S2 | 186.26 | | |
| 43 | 2923111-62-8 | 1-bromo-2-(2-ethynylphenyl)naphthalene | | | | |
| 44 | 2923115-67-5 | DMT-2'-O-C22-A(Bz)-CE-Phosphoramidite | C69H96N7O8P | 1182.52 | | |
| 45 | 2923115-75-5 | DMT-2'-O-C22-G(ibu)-CE-Phosphoramidite | C66H98N7O9P | 1164.5 | | |
| 46 | 2923115-82-4 | NA | C31H56N2O6 | 552.79 | | |
| 47 | 2923115-86-8 | DMTr-2'-O-C22-rU-3'-CE-Phosphoramidite | C61H91N4O9P | 1055.39 | | |
| 48 | 2923115-93-7 | DMT-2'-O-C22-C(Ac)-CE-Phosphoramidite | C63H94N5O9P | 1096.42 | | |
| 49 | 2923137-94-2 | (R)-YNT-3708 | | | | |
| 50 | 2923137-99-7 | YNT-3708 | | | | |
| 51 | 2923138-00-3 | (S)-YNT-3708 | | | | |
| 52 | 29232-39-1 | 2,3-Dibromo-5-methylpyridine | C6H5Br2N | 250.92 | 53.0 to 57.0 °C | |
| 53 | 29232-73-3 | methyl 3,5-bis(cyanomethyl)benzoate | C12H10N2O2 | 214.22 | | |
| 54 | 29232-93-7 | Pirimiphos-methyl | C11H20N3O3PS | 305.33 | 15°C | 9.9 mg l-1 (30 °C, pH 5.2) |
| 55 | 2923208-52-8 | ZNF207-IN-1 | | | | |
| 56 | 2923210-02-8 | ZSH-512 | | | | |
| 57 | 2923221-56-9 | 1H-Pyrazolo[4,3-c]quinoline, 3-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydro-7-isoquinolinyl)- | C27H24N4O2 | 436.51 | | |
| 58 | 2923230-41-3 | LpxH-IN-2 | C27H33ClF2N6O4S | 611.11 | | |
| 59 | 2923284-73-3 | Tovecimig | | | | |
| 60 | 2923284-76-6 | Lecankitug | | | | |
| 61 | 29233-23-6 | 4(3H)-Quinazolinone,2-ethyl-3-(2-furanylmethyl)- | C15H14N2O2 | 254.28386 | | |
| 62 | 29233-93-0 | α-(Trimethylsiloxy)benzeneacetic acid methyl ester | C12H18O3Si | 238.35 | | |
| 63 | 2923303-43-7 | tert-butyl 6-oxo-2,5-diazaspiro[3.5]non-7-ene-2-carboxylate | | 238.28 | | |
| 64 | 2923309-41-3 | JAK2 JH2 binder-1 | | | | |
| 65 | 2923310-64-7 | RAY1216 | | | | |
| 66 | 2923313-69-1 | PD-L1/HDAC-IN-1 | | | | |
| 67 | 2923314-22-9 | Pyridine, 2-chloro-4-(4-iodophenyl)- | | | | |
| 68 | 2923356-52-7 | Polθ-IN-7 | | | | |
| 69 | 2923356-56-1 | 2,3-Pyrrolidinedicarboxylic acid, 5-oxo-, 2-(1,1-dimethylethyl) 3-methyl ester, (2S,3S)- | C11H17NO5 | 243.26 | | |
| 70 | 2923365-71-1 | 5H-Pyrido[4,3-b]indol-3-amine, N-[2-[1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl]-4-pyrimidinyl]-5-(1-methylethyl)-7-(4-methyl-1-piperazinyl)-9-(2,2,2-trifluoroethoxy)- | C31H34F3N9O3S | 669.72 | | |
| 71 | 2923366-36-1 | hBChE-IN-2 | | | | |
| 72 | 2923388-14-9 | methyl 2-methyl-5-[[(2S)-1-methylazetidin-2-yl]methoxy]benzoate | C14H19NO3 | 249.31 | | |
| 73 | 29234-59-1 | Acetic acid, 2-[(6-chloro-2,1,3-benzothiadiazol-5-yl)oxy]-, ethyl ester | C10H9ClN2O3S | 272.71 | | |
| 74 | 29234-81-9 | 4-methylphenylphenoxyacetate | C15H14O3 | 242.26986 | | |
| 75 | 29234-83-1 | 4-chlorophenyl phenoxyacetate | C14H11ClO3 | 262.68834 | | |
| 76 | 29234-88-6 | Benzoic acid,4-chloro-, 2-methylpropyl ester | C11H13ClO2 | 212.67272 | | |
| 77 | 29234-97-7 | 6,13-Epoxydibenz[b,f]azecine, 14-methyl- | C18H13NO | 259.3 | | |
| 78 | 2923433-95-6 | APE1-IN-2 | C9H12Cl2N4O5Pt | 522.2 | | |
| 79 | 2923499-76-5 | Opamtistomig | | | | |
| 80 | 29235-08-3 | Benzenemethanamine, 4-(dimethylamino)-N-methyl-N-(phenylmethyl)- | C17H22N2 | 254.37 | | |
| 81 | 29235-36-7 | Methanediamine,1-(4-nitrophenyl)-N,N'-bis[(4-nitrophenyl)methylene]- | C21H15N5O6 | 433.3737 | | |
| 82 | 29235-52-7 | Benzoic acid, 2,4,5-trinitro- | C7H3N3O8 | 257.11 | | |
| 83 | 29235-71-0 | N-(4-hydroxyphenyl)-3-morpholin-4-yl-propanamide hydrochloride | C13H19ClN2O3 | | | |
| 84 | 29235-80-1 | Benzoic acid,4-[[3-(4-morpholinyl)-1-oxopropyl]amino]-, butyl ester, hydrochloride (1:1) | C18H27ClN2O4 | 370.87098 | | |
| 85 | 2923500-04-1 | 4-Quinolinecarboxamide, N-[(3R)-1-[4-cyano-2-(4-morpholinylcarbonyl)-6-(trifluoromethyl)phenyl]-3-pyrrolidinyl]-8-fluoro-1,2-dihydro-2-oxo- | C27H23F4N5O4 | 557.5 | | |
| 86 | 2923508-77-2 | (2S,3R)-N-(3-chloro-4-fluorophenyl)-1-(3-cyano-6-methyl-4-(trifluoromethyl)pyridin-2-yl)-3-(hydroxymethyl)-N-(methyl-d3)azetidine-2-carboxamide | | 459.84 | | |
| 87 | 2923519-78-0 | Antifungal agent 73 | C21H16Cl2N2O3 | 415.27 | | |
| 88 | 2923520-98-1 | RE-33 | C26H27ClN6O5 | 538.98 | | |
| 89 | 2923531-39-7 | Tubulin?inhibitor?32 | | | | |
| 90 | 2923531-50-2 | 1H-Indole-5-carboxylic acid, 3-[2-[[1-(2-chloro-4-methylphenyl)-2-oxo-3-pyrrolidinyl]amino]-2-oxoacetyl]-, methyl ester | C23H20ClN3O5 | 453.88 | | |
| 91 | 2923531-63-7 | DDO-3733 | C10H6F2N2OS | 240.23 | | |
| 92 | 2923532-92-5 | 3-ethynyl-6-(4-methoxyphenyl)-1,2,4,5-tetrazine | | | | |
| 93 | 2923539-60-8 | (rac)-5-(5-bromooxazolo[4,5-b]pyridin-2-yl)piperidin-2-one | | | | |
| 94 | 2923539-67-5 | 5-chloro-N-[(3R)-1-methyl-3-piperidyl]oxazolo[4.5-b]pyridin-2-amine | | | | |
| 95 | 2923539-80-2 | 5-bromo-N-[(3R)-1-ethyl-3-piperidyl]oxazolo[4.5-b]pyridin-2-amine | | | | |
| 96 | 2923540-06-9 | 5-bromo-N-[(3R)-1-methyl-3-piperidyl]oxazolo[4,5-b]pyridin-2-amine | | | | |
| 97 | 2923540-73-0 | 2,5-Dichloro-7-iodooxazolo[4,5-b]pyridine | C6HCl2IN2O | 314.9 | | |
| 98 | 2923540-98-9 | tert-butyl (3R)-3-[(5-bromooxazolo[4,5-b]pyridin-2-yl)amino]piperidine-1-carboxylate | | | | |
| 99 | 2923541-53-9 | tert-butyl (3R)-3-[[5-[2-methoxy-6-methyl-4-(trifluoromethyl)phenyl]oxazolo[4,5-b]pyridin-2-yl]amino]piperidine-1-carboxylate | | | | |
| 100 | 2923542-55-4 | 2141-V11 | | | | |
| 101 | 2923549-60-2 | 3-(4-bromo-2-chlorophenyl)piperidine-2,6-dione | C11H9BrClNO2 | 302.55 | | |
| 102 | 2923556-87-8 | Nivisnebart | | | | |
| 103 | 2923558-06-7 | Potravitug | | | | |
| 104 | 2923558-68-1 | Macupatide | | | | |
| 105 | 2923560-16-9 | 8-Bromo-3-chloro-5-iodoisoquinoline | | | | |
| 106 | 2923574-11-0 | Carbamic acid, N-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-3-oxo-1H-isoindol-5-yl]methyl]-, (2-methyl[1,1′-biphenyl]-3-yl)methyl ester | C29H27N3O5 | 497.54 | | |
| 107 | 2923582-29-8 | RMA-4219 | | | | |
| 108 | 29236-09-7 | 1H-Pyrrole-2,5-dione, 3,4-dichloro-1-(4-chlorophenyl)- | C10H4Cl3NO2 | 276.5 | | |
| 109 | 29236-11-1 | 3,4-DICHLORO-1-(4-NITRO-PHENYL)-PYRROLE-2,5-DIONE | C10H4Cl2N2O4 | 287.06 | | |
| 110 | 29236-13-3 | 1H-Pyrrole-2,5-dione, 3,4-dichloro-1-(2-methoxyphenyl)- | C11H7Cl2NO3 | 272.08 | | |
| 111 | 29236-85-9 | Nickel(2+),tris(picolinaldehyde oxime)-, diiodide (8CI) | C18H18I2N6NiO3 | 678.87626 | | |
| 112 | 29236-93-9 | 2,5-Diethoxy Thiophenol | C10H14O2S | 198.28 | | |
| 113 | 29236-95-1 | 2-(Butylthio)-1,4-diethoxybenzene | | | | |
| 114 | 2923660-91-5 | Paliperidone Impurity 35 | | | | |
| 115 | 2923661-84-9 | Amakusamine | C9H5Br2NO2 | 318.95 | | |
| 116 | 2923669-20-7 | INCB159020 | | | | |
| 117 | 2923669-28-5 | KRAS G12D inhibitor 28 | | | | |
| 118 | 2923670-16-8 | 4-Pyridazineacetic acid, 2,3-dihydro-2,6-dimethyl-α-methylene-3-oxo-, phenylmethyl ester | C16H16N2O3 | 284.31 | | |
| 119 | 2923674-83-1 | PAV-104 | C29H35N5O6S | 581.69 | | |
| 120 | 2923686-62-6 | 2-Pyridinecarboxamide, N-[1-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-4-piperidinyl]-6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]- | C38H37F2N9O6 | 753.76 | | |
| 121 | 2923687-56-1 | Itanistomig | | | | |
| 122 | 2923687-90-3 | 2-Pyridinecarboxylic acid, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]- | C20H19F2N5O3 | 415.39 | | |
| 123 | 2923694-73-7 | MTDB-Alkyne | | | | |
| 124 | 29237-05-6 | 2,5-Cyclohexadien-1-one, 4-[bis(4-hydroxy-3,5-dimethylphenyl)methylene]-2,6-dimethyl- | C25H26O3 | 374.47 | | |
| 125 | 29237-10-3 | 3-broMo-4-Methoxy-2-Methylaniline | C8H10BrNO | 216.08 | | |
| 126 | 29237-78-3 | DIETHYL ETHYLBROMOMALONATE | C9H15BrO4 | 267.12 | | |
| 127 | 29237-95-4 | Benzenemethanamine, N-chloro- | C7H8ClN | 141.6 | | |
| 128 | 2923700-82-5 | Everafenib | | | | |
| 129 | 2923722-02-3 | anti-TNBC agent-10 | | | | |
| 130 | 2923734-82-9 | (S,R,S)-AHPC-PEG5-Boc | | | | |
| 131 | 2923734-95-4 | (S,R,S)-AHPC-PEG2-C2-boc | | | | |
| 132 | 2923738-92-3 | NusB-IN-1 | | | | |
| 133 | 2923756-41-4 | NA | | 624.78 | | |
| 134 | 2923760-40-9 | 5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-[3-[(1,1-dimethylethoxy)carbonyl]-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- | C28H36FN5O5 | 541.62 | | |
| 135 | 29238-07-1 | 2-Tetradecylpentanedioic acid dimethyl ester | | | | |
| 136 | 29238-31-1 | Carbamic acid, (α-methylphenacyl)-, ethyl ester (8CI) | C12H15NO3 | 221.25 | | |
| 137 | 29238-38-8 | 1-(4-Methylphenoxy)-2-propanaMine HCl | C10H16ClNO | 201.69 | | |
| 138 | 29238-40-2 | 6-Demethyl 4-Methyl Mexiletine Hydrochloride | C11H18ClNO | 215.72 | 198-203°C | |
| 139 | 29238-81-1 | Phosphonic acid, P-(trichloromethyl)-, dimethyl ester | C3H6Cl3O3P | 227.41 | | |
| 140 | 2923800-62-6 | ATR-IN-23 | | | | |
| 141 | 2923811-72-5 | 3,5-Pyridinedicarboxylic acid, 4-(2-chlorophenyl)-2-[[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethoxy]methyl]-1,4-dihydro-6-methyl-, 3-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl] 5-methyl ester | C36H30ClN3O9 | 684.09 | | |
| 142 | 2923811-73-6 | 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-(2-aminoethyl) 5-methyl ester | C20H26ClN3O5 | 423.89 | | |
| 143 | 2923834-62-0 | N-((1s,3s)-3-(Methylamino)cyclobutyl)propane-1-sulfonamide hydrochloride | | | | |
| 144 | 2923841-98-7 | 2923841-98-7 | | | | |
| 145 | 2923843-85-8 | 4',4''',4''''',4'''''''-(ethene-1,1,2,2-tetrayl)tetrakis(3-hydroxy-[1,1'-biphenyl]-4-carbaldehyde) | | | | |
| 146 | 2923865-23-8 | Mezigdomide Impurity 23 | | | | |
| 147 | 2923865-76-1 | KRAS G12C-IN-70 | | | | |
| 148 | 2923867-57-4 | 4-Bromo-5-fluoro-1H-indazole-7-carboxylic acid | C8H4BrFN2O2 | 259.03 | | |
| 149 | 2923867-69-8 | 4-bromo-3,5-difluoro-1H-indazole-7-carboxylic acid | C8H3BrF2N2O2 | 277.02 | | |
| 150 | 2923867-75-6 | 1H-Indazole-7-carboxylic acid, 4-bromo-5-fluoro-3-methyl-, methyl ester | C10H8BrFN2O2 | 287.09 | | |
| 151 | 2923885-47-4 | DMBA-SIL-PNP | | | | |
| 152 | 2923885-49-6 | DMBA-SIL-Mal-MMAE | C72H106N8O20 | 1403.66 | | |
| 153 | 29239-07-4 | 2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-yl formate | C11H16O2 | 180.24 | | |
| 154 | 29239-28-9 | Mercury, hydroxy(phenylmethyl)- | C7H8HgO | 308.73 | | |
| 155 | 29239-56-3 | N,N-dimethyl-2-(2-methylphenoxy)acetamide | C11H15NO2 | 193.24 | | |
| 156 | 29239-85-8 | Phenol, 4,4'-[oxybis(2,1-ethanediyloxy-4,1-phenylenesulfonyl)]bis- | C28H26O9S2 | 570.63 | | |
| 157 | 29239-89-2 | 2-Methyl-4-ethylimidazole | C6H10N2 | 110.16 | | |
| 158 | 2923907-92-8 | GLI1-IN-1 | | 736.94 | | |
| 159 | 2923969-55-3 | Ritlecitinib Impurity 85 | C19H25N5O3 | 371.43 | | |
| 160 | 2923986-27-8 | MAT2A-IN-18 | | | | |
| 161 | 2923990-43-4 | BODIPYTMR-Xalkyne | C30H35BF2N4O3 | 548.43 | | |
| 162 | 2923999-01-1 | 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diamine, N6-[(2,4-difluorophenyl)methyl]-N4-(5-methyl-1H-pyrazol-3-yl)-1-(4-piperidinyl)- | C21H23F2N9 | 439.47 | | |